Cargando…

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome

PURPOSE: To investigate the clinical characteristics and therapeutic outcome of patients with neovascular age-related macular degeneration (nAMD) in 1 eye, without drusen in the fellow eye. PATIENTS AND METHODS: Medical records of 381 patients were analyzed to identify the cases. The main outcomes i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Wing H, van Dijk, Elon H C, Mohabati, Danial, Dijkman, Greet, Yzer, Suzanne, de Jong, Eiko K, Fauser, Sascha, Schlingemann, Reinier O, Hoyng, Carel B, Boon, Camiel J F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189970/ https://www.ncbi.nlm.nih.gov/pubmed/28053502 http://dx.doi.org/10.2147/OPTH.S122568

Ejemplares similares

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
por: Mohabati, Danial, et al.
Publicado: (2018)

GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification
por: van Dijk, Elon H. C., et al.
Publicado: (2020)

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2018)

Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2023)

Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2020)

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Feenstra, Helena M. A., et al.
Publicado: (2023)

Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration
por: van de Ven, Johannes P.H., et al.
Publicado: (2012)

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Whole Exome Sequencing in Patients with the Cuticular Drusen Subtype of Age-Related Macular Degeneration
por: Duvvari, Maheswara R., et al.
Publicado: (2016)

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3
por: Feenstra, Helena M. A., et al.
Publicado: (2022)

Genetic and environmental risk factors for extramacular drusen
por: Altay, Lebriz, et al.
Publicado: (2020)

Analysis of rare variants in the CFH gene in patients with the cuticular drusen subtype of age-related macular degeneration
por: Duvvari, Maheswara R., et al.
Publicado: (2015)

Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities
por: Brinks, Joost, et al.
Publicado: (2022)

Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
por: van Rijssen, Thomas J., et al.
Publicado: (2021)

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

Near-infrared reflectance imaging of neovascular age-related macular degeneration
por: Theelen, Thomas, et al.
Publicado: (2009)

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Increased pro-MMP9 plasma levels are associated with neovascular age-related macular degeneration and with the risk allele of rs142450006 near MMP9
por: Lauwen, Susette, et al.
Publicado: (2021)

SINGLE-SESSION BILATERAL REDUCED-SETTINGS PHOTODYNAMIC THERAPY FOR BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Pauleikhoff, Laurenz J.B., et al.
Publicado: (2023)

A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2016)

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
por: Breukink, Myrte B., et al.
Publicado: (2015)

European Prevalence of Polypoidal Choroidal Vasculopathy: A Systematic Review, Meta-Analysis, and Forecasting Study
por: van Dijk, Elon H. C., et al.
Publicado: (2022)

Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Clinical Characteristics of Neovascular Age-Related Macular Degeneration without Typical Drusen
por: Kamao, Hiroyuki, et al.
Publicado: (2021)

Analysis of hemopexin plasma levels in patients with age-related macular degeneration
por: Lauwen, Susette, et al.
Publicado: (2022)

Common and rare variants in patients with early onset drusen maculopathy
por: de Breuk, Anita, et al.
Publicado: (2022)

Exome sequencing in families with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)

Cushing’s Syndrome and Hypothalamic–Pituitary–Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy
por: van Haalen, Femke M., et al.
Publicado: (2018)

Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration
por: Saksens, Nicole T. M., et al.
Publicado: (2016)

Drusen and pigment abnormality predict the development of neovascular age-related macular degeneration in Japanese patients
por: Notomi, Shoji, et al.
Publicado: (2021)

Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema
por: Schreur, Vivian, et al.
Publicado: (2018)

Genetic screening for macular dystrophies in patients clinically diagnosed with dry age‐related macular degeneration
por: Kersten, Eveline, et al.
Publicado: (2018)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Cuticular drusen associated with aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy)
por: Fragiotta, Serena, et al.
Publicado: (2018)

Complete Resolution of Central Soft Drusen without Geographic Atrophy or Choroidal Neovascularization
por: Zeng, Rebecca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h2kv7u1i6a0eaqejmo215pm42d